Bernd Flath

1.1k total citations
40 papers, 829 citations indexed

About

Bernd Flath is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Bernd Flath has authored 40 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 9 papers in Genetics. Recurrent topics in Bernd Flath's work include Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Bernd Flath is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Bernd Flath collaborates with scholars based in Germany, United States and Estonia. Bernd Flath's co-authors include Peter Schmid, Kurt Possinger, Diana Lüftner, K. Possinger, Christian Jehn, C. Jehn, Orhan Sezer, Sebastian Pfeiffer, E. Späth‐Schwalbe and Anne C. Regierer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Bernd Flath

38 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernd Flath Germany 16 434 214 116 101 92 40 829
B. Storer United States 15 246 0.6× 104 0.5× 46 0.4× 73 0.7× 193 2.1× 20 815
Patricia Griffin United States 13 292 0.7× 202 0.9× 27 0.2× 80 0.8× 86 0.9× 36 1.1k
Suxia Lin China 14 349 0.8× 172 0.8× 33 0.3× 40 0.4× 122 1.3× 57 1.2k
Sylvia Hu United States 13 483 1.1× 389 1.8× 34 0.3× 35 0.3× 81 0.9× 26 1.1k
Tomoko Yamazaki Japan 20 430 1.0× 187 0.9× 43 0.4× 27 0.3× 305 3.3× 75 1.4k
Stephen P. Malkoski United States 18 390 0.9× 399 1.9× 20 0.2× 81 0.8× 544 5.9× 35 1.4k
Ichiro Kohno Japan 17 235 0.5× 126 0.6× 136 1.2× 13 0.1× 347 3.8× 56 1.2k
Parvin Ganjei‐Azar United States 18 536 1.2× 358 1.7× 22 0.2× 24 0.2× 345 3.8× 55 1.4k
Lynda M. Vrooman United States 20 252 0.6× 145 0.7× 18 0.2× 52 0.5× 171 1.9× 56 1.4k
Fumiaki Sugiura Japan 13 153 0.4× 39 0.2× 28 0.2× 130 1.3× 161 1.8× 25 730

Countries citing papers authored by Bernd Flath

Since Specialization
Citations

This map shows the geographic impact of Bernd Flath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Flath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Flath more than expected).

Fields of papers citing papers by Bernd Flath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Flath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Flath. The network helps show where Bernd Flath may publish in the future.

Co-authorship network of co-authors of Bernd Flath

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Flath. A scholar is included among the top collaborators of Bernd Flath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Flath. Bernd Flath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jehn, C., Bernd Flath, Matthew Krebs, et al.. (2012). Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer. Breast Cancer Research and Treatment. 136(3). 789–794. 55 indexed citations
2.
Regierer, Anne C., Andrea Stroux, Annette Dieing, et al.. (2008). Contrast-Enhancing Meningeal Lesions Are Associated with Longer Survival in Breast Cancer-Related Leptomeningeal Metastasis. Breast Care. 3(2). 118–123. 8 indexed citations
3.
Possinger, K., et al.. (2008). Hormontherapie beim metastasierten Mammakarzinom der Frau. DMW - Deutsche Medizinische Wochenschrift. 116(50). 1921–1929.
4.
Neumann, Katja, Michaela Endres, Jochen Ringe, et al.. (2007). BMP7 promotes adipogenic but not osteo‐/chondrogenic differentiation of adult human bone marrow‐derived stem cells in high‐density micro‐mass culture. Journal of Cellular Biochemistry. 102(3). 626–637. 49 indexed citations
5.
Jehn, Christian, Sebastian Pfeiffer, Michael Krebs, et al.. (2006). Biomarkers of depression in cancer patients. Cancer. 107(11). 2723–2729. 106 indexed citations
6.
Schmid, Peter, Bernd Flath, V. Heilmann, et al.. (2005). Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study. Investigational New Drugs. 23(4). 349–356. 4 indexed citations
7.
Schmid, Peter, V. Heilmann, Carsten‐Oliver Schulz, et al.. (2005). Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study. Journal of Cancer Research and Clinical Oncology. 131(9). 568–574. 12 indexed citations
8.
9.
Lüftner, Diana, et al.. (2004). Serum HER-2/neu as a prediction and monitoring parameter in a phase II study with weekly paclitaxel in metastatic breast cancer.. PubMed. 24(2B). 895–906. 19 indexed citations
10.
Dieing, Annette, Carsten‐Oliver Schulz, Peter Schmid, et al.. (2004). Orbital metastases in breast cancer: report of two cases and review of the literature. Journal of Cancer Research and Clinical Oncology. 130(12). 745–748. 40 indexed citations
12.
Späth‐Schwalbe, E., Bernd Flath, O. Kaufmann, et al.. (2000). An unusual case of leukemic non-Hodgkin's lymphoma with blastic transformation. Annals of Hematology. 79(4). 217–221. 3 indexed citations
13.
Kaufmann, Olaf, Bernd Flath, E. Späth‐Schwalbe, Kurt Possinger, & Manfred Dietel. (1999). Immunohistochemical Detection of CD10 with Monoclonal Antibody 56C6 on Paraffin Sections. American Journal of Clinical Pathology. 111(1). 117–122. 50 indexed citations
14.
Flath, Bernd, et al.. (1999). Comparison of different staining procedures for the flow cytometric analysis of U-937 cells infected with different Leishmania-species. Journal of Microbiological Methods. 37(2). 123–138. 15 indexed citations
15.
Schmid, Peter, et al.. (1999). Prolonged infusion of gemcitabine in stage IV breast cancer. Anti-Cancer Drugs. 10(6). 525–532. 40 indexed citations
16.
Flath, Bernd, et al.. (1999). Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer. Anti-Cancer Drugs. 10(7). 625–632. 85 indexed citations
17.
Flath, Bernd, et al.. (1998). Mixed infection of human U-937 cells by two different species of Leishmania.. American Journal of Tropical Medicine and Hygiene. 59(2). 182–188. 14 indexed citations
18.
Lüftner, Diana, et al.. (1998). Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study. Investigational New Drugs. 16(2). 141–146. 22 indexed citations
19.
Massenkeil, Gero, E. Späth‐Schwalbe, Bernd Flath, et al.. (1998). Transient tetraparesis after intrathecal and high-dose systemic methotrexate. Annals of Hematology. 77(5). 239–242. 9 indexed citations
20.
Flath, Bernd, Boris Rolinski, & Adelbert A. Roscher. (1997). Simple high-performance liquid chromatographic method for the detection of phenylpropionylglycine in urine as a diagnostic tool in inherited medium-chain acyl-coenzyme A dehydrogenase deficiency. Journal of Chromatography B Biomedical Sciences and Applications. 694(1). 227–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026